Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint.
Authors: Zamith Cunha Rodrigo, Zannoni Augusta, Salamanca Giulia, De Silva Margherita, Rinnovati Riccardo, Gramenzi Alessandro, Forni Monica, Chiocchetti Roberto
Journal: Frontiers in veterinary science
Summary
# Editorial Summary The endocannabinoid system is increasingly recognised as a regulator of joint inflammation and tissue homeostasis, yet its specific expression profile in equine synovial tissue remained poorly characterised despite the metacarpophalangeal joint's susceptibility to osteoarthritis under the extreme loading demands of equine locomotion. Rodrigo and colleagues conducted immunohistochemical analysis of synovial membrane samples from clinically normal horse forelimbs to map the localisation and distribution of cannabinoid receptors (CB1 and CB2) alongside related receptors (TRPV1, GPR55, and PPARα) that modulate inflammatory and proliferative responses. All five receptor types were demonstrated within the synovial membrane, with CB2, TRPV1, and GPR55 showing particularly robust expression in synovial fibroblasts and lining cells—the cellular populations most directly involved in joint inflammation and matrix remodelling during osteoarthritis development. These findings provide an anatomical foundation for understanding endocannabinoid signalling in equine joint pathology and suggest that cannabinoid-based therapeutics merit further investigation as potential disease-modifying agents for metacarpophalangeal joint conditions. For practitioners managing joint problems in performance horses, this work strengthens the rationale for exploring cannabinoid interventions whilst highlighting the need for functional studies to determine whether receptor activation could genuinely suppress inflammatory cascades or slow cartilage degradation in clinical disease.
Read the full abstract on PubMed
Practical Takeaways
- •The presence of cannabinoid receptors in equine joint synovium provides a biological basis for investigating cannabinoid compounds as potential anti-inflammatory therapies for joint disease in horses
- •Understanding receptor distribution in the MCP joint may inform future development of targeted treatments for joint inflammation and early osteoarthritis
- •This foundational work supports further investigation into endocannabinoid system modulation as a novel therapeutic approach for performance horses at high risk of MCP joint pathology
Key Findings
- •Cannabinoid receptors (CB1, CB2) and cannabinoid-related receptors (TRPV1, GPR55, PPARα) are expressed in equine metacarpophalangeal joint synovial membrane
- •Expression patterns suggest the endocannabinoid system is present and potentially functional in equine joint tissue
- •These receptors modulate proliferative and secretory responses relevant to joint inflammation and osteoarthritis pathophysiology